Abstract

The mu-opioid receptor antagonist naltrexone, which is approved for the treatment of alcohol and opiate dependence, has a black-box warning for

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call